Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the prognosis of cancer patients. In this work, we used a clustering algorithm to divide patients into different subtypes in order to reduce the heterogeneity of the cancer patients in each subtype. Based on the hypothesis that the gene co-expression network may reveal relationships among genes, some communities in the network could influence the prognosis of cancer patients and all the prognosis-related communities could fully reveal the prognosis of cancer patients. To predict the prognosis for cancer patients in each subtype, we adopted an ensemble classifier based on the gene co-expression network of the corresponding subtype. Using the gene expre...
Gene expression provides rich information. Successful application has made to predict prognosis of s...
<div><p>The stratification of cancer into subtypes that are significantly associated with clinical o...
The stratification of cancer into subtypes that are significantly associated with clinical outcomes ...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
SummaryOvarian cancer has a poor prognosis, with different outcomes for different patients. The mech...
Ovarian cancer has a poor prognosis, with different outcomes for different patients. The mechanism u...
Gene expression provides rich information. Successful application has made to predict prognosis of s...
<div><p>The stratification of cancer into subtypes that are significantly associated with clinical o...
The stratification of cancer into subtypes that are significantly associated with clinical outcomes ...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
Due to the high heterogeneity and complexity of cancer, it is still a challenge to predict the progn...
SummaryOvarian cancer has a poor prognosis, with different outcomes for different patients. The mech...
Ovarian cancer has a poor prognosis, with different outcomes for different patients. The mechanism u...
Gene expression provides rich information. Successful application has made to predict prognosis of s...
<div><p>The stratification of cancer into subtypes that are significantly associated with clinical o...
The stratification of cancer into subtypes that are significantly associated with clinical outcomes ...